{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:26:16Z","timestamp":1786991176260,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170388"],"award-info":[{"award-number":["82170388"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370300"],"award-info":[{"award-number":["82370300"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["20214Y0152"],"award-info":[{"award-number":["20214Y0152"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["2022YQ023"],"award-info":[{"award-number":["2022YQ023"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014764","name":"China International Medical Foundation","doi-asserted-by":"publisher","award":["Z-2019-42-1908-3"],"award-info":[{"award-number":["Z-2019-42-1908-3"]}],"id":[{"id":"10.13039\/501100014764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Shanghai Municipality Science and Technology Commission","doi-asserted-by":"publisher","award":["21XD1434700"],"award-info":[{"award-number":["21XD1434700"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jacadv.2024.101350","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T16:21:16Z","timestamp":1729268476000},"page":"101350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association Between Systolic Blood Pressure Time in Target Range Indices and Adverse Cardiovascular Outcomes"],"prefix":"10.1016","volume":"3","author":[{"given":"Moran","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rusitanmujiang","family":"Maimaitiaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.jacadv.2024.101350_bib1","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa2206916","article-title":"Global effect of modifiable risk factors on cardiovascular disease and mortality","volume":"389","author":"Magnussen","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.jacadv.2024.101350_bib2","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"J\u00a0Hypertens"},{"issue":"38","key":"10.1016\/j.jacadv.2024.101350_bib3","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.jacadv.2024.101350_bib4","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2021.01.014","article-title":"Systolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension","volume":"77","author":"Fatani","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jacadv.2024.101350_bib5","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1161\/HYPERTENSIONAHA.122.20711","article-title":"Systolic blood pressure time in target range and cognitive outcomes: insights from the SPRINT MIND trial","volume":"80","author":"Li","year":"2023","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.jacadv.2024.101350_bib6","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1161\/HYPERTENSIONAHA.123.21651","article-title":"Systolic blood pressure time in target range and incident atrial fibrillation in patients with hypertension: insights from the SPRINT trial","volume":"80","author":"Wang","year":"2023","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.jacadv.2024.101350_bib7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/HYPERTENSIONAHA.122.20141","article-title":"Systolic blood pressure time in target range and major adverse kidney and cardiovascular events","volume":"80","author":"Buckley","year":"2023","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.jacadv.2024.101350_bib8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jchf.2022.01.010","article-title":"Prognostic value of time in blood pressure target range among patients with heart failure","volume":"10","author":"Chen","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacadv.2024.101350_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110600","article-title":"Longer time in blood pressure target range improves cardiovascular outcomes among patients with Type 2 diabetes: a secondary analysis of a randomized clinical trial","volume":"198","author":"Chen","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jacadv.2024.101350_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ahj.2022.12.011","article-title":"Systolic blood pressure time in target range and long-term outcomes in patients with ischemic cardiomyopathy","volume":"258","author":"Fu","year":"2023","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.jacadv.2024.101350_bib11","article-title":"Time in target range for systolic blood pressure and cardiovascular outcomes in patients with heart failure with preserved ejection fraction","volume":"11","author":"Huang","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.jacadv.2024.101350_bib12","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1177\/1740774514537404","article-title":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"11","author":"Ambrosius","year":"2014","journal-title":"Clin Trials"},{"issue":"10393","key":"10.1016\/j.jacadv.2024.101350_bib13","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(23)00733-X","article-title":"Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients","volume":"401","author":"Staplin","year":"2023","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jacadv.2024.101350_bib14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/eurjpc\/zwad083","article-title":"Association of long-term time in target range for systolic blood pressure with cardiovascular risk in the elderly: a Chinese veteran cohort study","volume":"30","author":"Lin","year":"2023","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"10.1016\/j.jacadv.2024.101350_bib15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.kint.2023.12.008","article-title":"Findings from the KNOW-CKD Study indicate that higher systolic blood pressure time in target range is associated with a lower risk of chronic kidney disease progression","volume":"105","author":"Park","year":"2024","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.jacadv.2024.101350_bib16","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/STROKEAHA.123.044358","article-title":"Influence of time to achieve target systolic blood pressure on outcome after intracerebral hemorrhage: the blood pressure in acute stroke collaboration","volume":"55","author":"Wang","year":"2024","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.jacadv.2024.101350_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/HJH.0000000000003331","article-title":"Time of blood pressure in target range in acute ischemic stroke","volume":"41","author":"Kakaletsis","year":"2023","journal-title":"J\u00a0Hypertens"},{"issue":"20","key":"10.1016\/j.jacadv.2024.101350_bib18","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.jacc.2022.08.802","article-title":"Cardiovascular risk reduction after renal denervation according to time in therapeutic systolic blood pressure range","volume":"80","author":"Mahfoud","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X24006306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X24006306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:32:35Z","timestamp":1778934755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X24006306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2772963X24006306"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2024.101350","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Systolic Blood Pressure Time in Target Range Indices and Adverse Cardiovascular Outcomes","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2024.101350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101350"}}